课题基金 / 基金详情

Min(d)ing the Gap: Toward an Ethics Framework for Post-Market Surveillance of Prescription Drugs in Underrepresented Populations

Min(d)ing the Gap: Toward an Ethics Framework for Post-Market Surveillance of Prescription Drugs in Underrepresented Populations
缩小差距:建立针对代表性不足人群的处方药上市后监管的道德框架
批准号:
244026
负责人:
Thompson Alison K
金额:
$3.64万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2011
资助国家:
加拿大
项目状态:
已结题
起止时间:
2011-10-01 至 2012-10-01

项目摘要

项目成果

Thompson Alison K的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The underrepresentation and exclusion of women, children, older people, First Nations, Metis and Inuit peoples in clinical trials necessitates post-market surveillance of efficacy and safety in these populations. However, the biological risk and social vu
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SAFER: Study to Articulate a Framework for Ethical Reflection in Post-Market Pharmacovigilance
  • 批准号:
    300097
  • 项目类别:
    Operating Grants
  • 资助金额:
    $11.92万
  • 财政年份:
    2013
  • 负责人:
    Thompson Alison K
  • 依托单位:
海外基金